Cancer Causes & Control

, Volume 25, Issue 12, pp 1707–1715 | Cite as

The risk of breast cancer associated with specific patterns of migraine history

  • Sarah J. LowryEmail author
  • Kathleen E. Malone
  • Kara L. Cushing-Haugen
  • Christopher I. Li
Original paper



Studies have suggested that a history of migraines may be associated with a lower risk of some types of breast cancer, though biological mechanisms are unclear. Identifying specific characteristics of migraines which are most strongly associated with breast cancer risk could improve our understanding of this relationship.


We ascertained specific characteristics of women’s migraine histories (severity, timing features, and presence of migraine aura). We used polytomous logistic regression to estimate the risk of ER+ ductal, ER− ductal, ER+ lobular, and ER+ ductal–lobular breast cancer associated with self-reported characteristics of migraine history. A total of 715 breast cancer cases (276 ER+ ductal, 46 ER− ductal, 191 ER+ lobular, and 202 ER+ ductal–lobular) and 376 controls ages 55–74 years were included in this population-based case–control study.


Compared to women without a migraine history, women with a >30-year history of migraines had a 60 % (95 % CI 0.2–0.6) lower risk of ER+ ductal breast cancer; those who had their first migraine before age 20 had 50 % lower risks of ER+ ductal and ER+ lobular breast cancer (both 95 % CIs 0.3–0.9), and women who experienced migraine with aura had 30 % (95 % CI 0.5–0.98) and 40 % (95 % CI 0.4–0.9) lower risks of ER+ ductal and ER+ lobular breast cancer, respectively.


The lower risk of ER+ breast cancer associated with migraine appears to be limited to those women with early onset or long duration of migraine history, or those who experienced migraine with aura. This expands our understanding of the relationship between migraine and breast cancer and provides additional insight into potential underlying biological mechanisms.


Migraine Breast cancer Case–control Hormones Estrogen Postmenopausal 



We would like to thank several people who contributed to this work, including Kassidy Benoscek, David Grogan, Carolyn Howard, Dick Jacke, Rob McKenna, Anne Oswald, Georgene Ranney, April Reitan, LJ Sweetland, Mei-Tzu Tang, Camille Taylor, and Sarah Taylor. This study was supported by two Grants from the National Cancer Institute: NCI: R03-CA135688 and NCI: R01-CA85913, and the manuscript was supported by training Grant: 2T32CA009168-36.

Conflict of interest

The authors state they have no conflicts of interest.


  1. 1.
    Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, Michael Y, O’Sullivan MJ, Stefanick ML, Prentice R (2010) Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol 28(6):1005–1010. doi: 10.1200/JCO.2009.25.0423 PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Deapen D, Burkman RT, Folger SG, McDonald JA, Spirtas R (2009) Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 18(7):2030–2034. doi: 10.1158/1055-9965.EPI-09-0291 PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI (2008) Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17(11):3116–3122. doi: 10.1158/1055-9965.EPI-08-0527 PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Winter AC, Rexrode KM, Lee IM, Buring JE, Tamimi RM, Kurth T (2013) Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control 24(1):81–89. doi: 10.1007/s10552-012-0092-x PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Dumitrescu RG, Cotarla I (2005) Understanding breast cancer risk—Where do we stand in 2005? J Cell Mol Med 9(1):208–221PubMedCrossRefGoogle Scholar
  6. 6.
    Bousser MG (2004) Estrogens, migraine, and stroke. Stroke 35(11 Suppl 1):2652–2656. doi: 10.1161/01.STR.0000143223.25843.36 PubMedCrossRefGoogle Scholar
  7. 7.
    MacGregor EA (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3(6):354–361. doi: 10.1016/S1474-4422(04)00768-9 PubMedCrossRefGoogle Scholar
  8. 8.
    Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB (2013) Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. doi: 10.1111/head.12150 Google Scholar
  9. 9.
    Allais G, Castagnoli Gabellari I, De Lorenzo C, Mana O, Benedetto C (2011) Oral contraceptives in migraine therapy. Neurol Sci 32(Suppl 1):S135–S139. doi: 10.1007/s10072-011-0538-z PubMedCrossRefGoogle Scholar
  10. 10.
    Sacco S, Ricci S, Degan D, Carolei A (2012) Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain 13(3):177–189. doi: 10.1007/s10194-012-0424-y PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Brandes JL (2006) The influence of estrogen on migraine: a systematic review. JAMA 295(15):1824–1830. doi: 10.1001/jama.295.15.1824 PubMedCrossRefGoogle Scholar
  12. 12.
    Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR (2008) Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal–lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 17(1):43–50. doi: 10.1158/1055-9965.EPI-07-0558 PubMedCrossRefGoogle Scholar
  13. 13.
    Bigal M, Krymchantowski AV, Lipton RB (2009) Barriers to satisfactory migraine outcomes. What have we learned, where do we stand? Headache 49(7):1028–1041. doi: 10.1111/j.1526-4610.2009.01410.x PubMedCrossRefGoogle Scholar
  14. 14.
    Cady R, Dodick DW (2002) Diagnosis and treatment of migraine. Mayo Clinic Proc 77(3):255–261. doi: 10.4065/77.3.255 CrossRefGoogle Scholar
  15. 15.
    Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160Google Scholar
  16. 16.
    Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7(1):3–15PubMedCrossRefGoogle Scholar
  17. 17.
    Calhoun AH (2012) Current topics and controversies in menstrual migraine. Headache 52(Suppl 1):8–11. doi: 10.1111/j.1526-4610.2012.02130.x PubMedCrossRefGoogle Scholar
  18. 18.
    Brandes JL (2012) Migraine in women. Continuum 18(4):835–852. doi: 10.1212/01.CON.0000418646.70149.71 PubMedGoogle Scholar
  19. 19.
    Greco R, Tassorelli C, Mangione AS, Smeraldi A, Allena M, Sandrini G, Nappi G, Nappi RE (2013) Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache 53(2):288–296. doi: 10.1111/j.1526-4610.2012.02249.x PubMedCrossRefGoogle Scholar
  20. 20.
    Eikermann-Haerter K, Kudo C, Moskowitz MA (2007) Cortical spreading depression and estrogen. Headache 47(Suppl 2):S79–S85. doi: 10.1111/j.1526-4610.2007.00818.x PubMedCrossRefGoogle Scholar
  21. 21.
    Shyti R, de Vries B, van den Maagdenberg A (2011) Migraine genes and the relation to gender. Headache 51(6):880–890. doi: 10.1111/j.1526-4610.2011.01913.x PubMedCrossRefGoogle Scholar
  22. 22.
    Sachs M, Pape HC, Speckmann EJ, Gorji A (2007) The effect of estrogen and progesterone on spreading depression in rat neocortical tissues. Neurobiol Dis 25(1):27–34. doi: 10.1016/j.nbd.2006.08.013 PubMedCrossRefGoogle Scholar
  23. 23.
    Chauvel V, Vamos E, Pardutz A, Vecsei L, Schoenen J, Multon S (2012) Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat. Exp Neurol 236(2):207–214. doi: 10.1016/j.expneurol.2012.05.002 PubMedCrossRefGoogle Scholar
  24. 24.
    Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365–391. doi: 10.1146/annurev-physiol-030212-183717 PubMedCrossRefGoogle Scholar
  25. 25.
    Vecchia D, Pietrobon D (2012) Migraine: A disorder of brain excitatory–inhibitory balance? Trends Neurosci 35(8):507–520. doi: 10.1016/j.tins.2012.04.007 PubMedCrossRefGoogle Scholar
  26. 26.
    Kudo C, Haerter K, Moskowitz MA, Ayata C (2006) Estrogen modulates the susceptibility to cortical spreading depression, in vivo. Paper presented at the Society for Neuroscience, Atlanta, GA, 17 October 2006Google Scholar
  27. 27.
    Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst 102(18):1422–1431. doi: 10.1093/jnci/djq316 PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Coronado GD, Beasley J, Livaudais J (2011) Alcohol consumption and the risk of breast cancer. Salud Publica Mex 53(5):440–447PubMedGoogle Scholar
  29. 29.
    Kabat GC, Kim M, Phipps AI, Li CI, Messina CR, Wactawski-Wende J, Kuller L, Simon MS, Yasmeen S, Wassertheil-Smoller S, Rohan TE (2011) Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 22(5):775–783. doi: 10.1007/s10552-011-9750-7 PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Sarah J. Lowry
    • 1
    • 2
    Email author
  • Kathleen E. Malone
    • 1
    • 2
  • Kara L. Cushing-Haugen
    • 1
  • Christopher I. Li
    • 1
    • 2
  1. 1.Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA
  2. 2.Department of Epidemiology, School of Public Health and Community MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations